“…Zhang et al 63 proposed applying endogenous BM-MSC to a subcutaneous root canal tooth to a regenerative tissue after the systemic homing in the root canal, driven by the use of the stromal cell-derived factor-1 (SDF-1). The BC, blood clot; bFGF, basic fibroblast growth factor; BMP, bone morphogenetic protein; BMSC, bone marrow mesenchyme stem cell; CC, costal chondrocyte; CDHA, calcium carbonate hydroxyapatite; CNCC, cranial neural crest cell; CXCL14, chemokine (CXC motif) ligand-14; DFSC, dental follicle stem cell; DPSC, dental pulp stem cell; FGF, fibroblast growth factor; GCSF, granulocyte colony-stimulating factor; GF, growth factors; HA, hydroxyapatite; iPS, induced pluripotent stem cell; MCP1, monocyte chemoattractant protein-1; MSC, mesenchymal stem cell; MTA, mineral trioxide aggregate; NA, not exogenously added; ND, not determined; NGF, nerve growth factor; PCL, polycaprolactone; PGA, polyglycolic acid; PGDF, platelet-derived growth factor; PLGA, polylactic-co-glycolic acid; PLLA, poly-L-lactic acid; PRF, platelet-rich fibrin; PRP, platelet-rich plasma; REP, regenerative endodontic procedure; SCAP, stem cell of the apical papilla; SHED, stem cell from human exfoliated deciduous teeth; TCP, tricalcium phosphate; TDM, treated dentin matrix; TGF, transforming growth factor; VEGF, vascular endothelial growth factor; DBCs, dental bud cells use of dentine-matrix-scaffolding cells was associated to the differentiation of the stem cells in a dentinal tubule in polarized odontoblast-like cells 62 .…”